Bevacizumab Adcd + Irinotecan Interaction
Minorinteraction on record
Description
No clinically meaningful effect on pharmacokinetics of irinotecan or its active metabolite SN38 when administered with bevacizumab.
Source: NLP:bevacizumab-adcd
No clinically meaningful effect on pharmacokinetics of irinotecan or its active metabolite SN38 when administered with bevacizumab.
Source: NLP:bevacizumab-adcd